Skip to main content

Hidradenocarcinoma

  • Chapter
  • First Online:
Book cover Rare Malignant Skin Tumors
  • 1467 Accesses

Abstract

Hidradenocarcinoma, first reported by Keasby and Hadley in 1954, refers to the malignant counterpart of hidradenoma and may be of apocrine or eccrine lineage. It is a rare neoplasm accounting for 6 % of malignant eccrine tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  • Honda Y, Tanigawa H, Harada M, Fukushima S, Masuguchi S, Ishihara T, Ihn H, Iyama K. Hidradenocarcinoma showing prominent mucinous and squamous differentiation and associated pagetoid cells. J Cutan Pathol. 2013;40:503–8.

    Article  PubMed  Google Scholar 

  • Kazakov DV, Ivan D, Kutzner H, Spagnolo DV, Grossmann P, Vanecek T, et al. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation. Am J Dermatopathol. 2009;31:236–47.

    Article  PubMed  Google Scholar 

  • Keasby LE, Hadley GG. Clear cell hidradenoma: report of three cases with widespread metastases. Cancer. 1954;7:934–52.

    Article  Google Scholar 

  • Ko CJ, Cochran AJ, Eng W, Blinder SW. Hidradenocarcinoma: a histological and immunohistochemical study. J Cutan Pathol. 2006;33:726–30.

    Article  PubMed  Google Scholar 

  • Lerner A, Beckford A, Ugent S, Goldberg L, Jalisi S, Demierre MF. Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment. Arch Dermatol. 2011;147:998–9.

    Article  PubMed  Google Scholar 

  • Mitamura Y, Nakahara T, Furue M. Clear cell hidradenocarcinoma mimicking pyogenic granuloma after repeated surgical excision. Dermatol Surg. 2014;40:211–2.

    Article  CAS  PubMed  Google Scholar 

  • Souvatzidis P, Sbano P, Mandato F, Fimiani M, Castelli A. Malignant nodular hidradenoma of the skin: report of seven cases. J Eur Acad Dermatol Venereol. 2008;22:549–54.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Franco Rongioletti M.D. .

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rongioletti, F. (2015). Hidradenocarcinoma. In: Rare Malignant Skin Tumors. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2023-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2023-5_19

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2022-8

  • Online ISBN: 978-1-4939-2023-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics